Publications
BioCentury Publications
REALIZE SIGNIFICANT DISCOUNTS ON BIOCENTURY'S PUBLICATIONS AND DATA SOLUTIONS
BioCentury is recognized as the ESSENTIAL provider of independent, informed business intelligence. Its information platform combines analysis and data to regularly affect decisions made by bio-industry leaders and investors throughout the world.
Your benefits:
New subscribers
- Access to BioCentury's global industry analysis and data at a reduced rate for new subscribers
- Significant discounts on a one-year, single-user subscription to two weekly publications: the flagship BioCentury, the Bernstein Report on BioBusiness and the BioCentury Part II compendium of corporate, clinical and financial transactions, as well as the daily BioCentury Extra newspaper. New subscribers that are BIOTECanada Corporate A members in good standing with less than 50 employees engaged in drug/diagnostic development are eligible.
- 33% discount when you increase your BioCentury publications subscription to a 10-user group account
- 33% discount to the Data Solutions -- BioCentury Online Intelligence (BCIQ) and BioCentury Archives -- for new subscribers for one year.
- One month free trial for all publications
Current subscribers
- 33% discount when you increase your BioCentury publications subscription to a 10-user group account
- 33% discount when you upgrade your subscription to include the Data Solutions: BioCentury Online Intelligence (BCIQ) and BioCentury Archives
How it works:
Contact Subscriber Service Manager Andy Heller at BioCentury Publications, Inc.
Office: (781) 378-2011, Mobile: (617) 922-2257, Email: aheller@biocentury.com
Find out more: www.biocentury.com
BioCentury's mission is to provide value-added information and analysis for biotech and pharma companies, investors, academia and government on the strategic issues essential to the formation, development and sustainability of biopharmaceutical ventures. Our breadth of coverage includes corporate strategy, partnering, translational science, clinical data, public policy and the financing markets. All of this is supported by an in-house data warehouse that is now available to subscribers through BioCentury Online Intelligence (BCIQ).
BioWorld Publications
WORLDWIDE BIOTECHNOLOGY NEWS AND INFORMATION
90% off cover price for BioWorld Today and BioWorld Financial Watch for BIOTECanada Corporate A members
SAVE $3000 US if you subscribe to both publications
Enhance your success in the business of biotech with the newspaper of record for the industry. Delivering insider intelligence every business morning, you have access to a wide range of issues dramatically affecting the industry, including: Scientific milestones, capital sources and venture capital financing, corporate financial and stock performance, strategic alliances, agreements, sales and mergers, FDA and congressional actions.
Your benefits:
- Exceptional savings on annual subscription fees
- BioWorld Today for only US$241
- BioWorld Insight for only US$136 - E-mail delivery directly to you every business morning in an easy-to-read, pdf format
- Weekly reports from BioWorld Financial Watch give you a complete view of the business side of biotechnology
- Ability to monitor collaborations, public and private financings, clinical trials and FDA submissions, stock market activity, and underwriter and venture capital portfolio performances through one source
How it works:
Sign up directly with BIOTECanada.
Contact:
BIOTECanada
Janice Burke
Tel: 613-230-5585 ext 223
Email: janice.burke@biotech.ca
Additional Offer!
Published by the editors of
BioWorld Today, the newspaper of record for the biotechnology industry, the new
BioWorld Executive Compensation Report 2010, provides you with a variety of perspectives on compensation issues by means of key statistics and graphic analyses.
BIOTECanada is pleased to offer our Schedule A members the BioWorld® Executive Compensation Report 2010 for $59.00
- 90% off the regular rate!
Contact BIOTECanada for more information.
Burrill & Company
YOUR GATEWAY TO THE GLOBAL LIFE SCIENCES INDUSTRY
Burrill & Company provides a gateway into the biotechnology and life sciences global world through its publications and events. The Media Group's goal is to provide the latest insight, intelligence and information tailored for the senior executive. Stay current and interact with the leading experts and thought leaders in your field of interest. Subscribe to the publications listed below. Access market intelligence in hard copy publications, or online.
Your benefits:
Receive 40% off the list price of Burrill & Company publications, including:
- The Burrill Stem Cell Report (4/yr), $495
- The Burrill Stem Cell Webcast/CD-Rom, $495
- The Burrill Personalized Medicine Report (4/yr), $495
- Biotech 2007, $395 +shipping
- Biotech 2008, $395 + shipping
- The Burrill Canadian Biotech News (48/yr) $475
- The Journal of Life Sciences (6/yr), $85
- The Burrill Biotechnology Intelligence Report (4/yr), $999
- Biotech 20 Year CD (1986-2006), $699
All prices in US dollars. Discounts available to BIOTECanada members only.
How it works:
Contact Peter Winter, Editorial Director (pwinter@b-c.com) to sign up for any of the publications and obtain your special discounted price. Visit http://www.burrillandco.com/burrill/publications for a complete list of eligible publications.
Founded in 1994, Burrill & Company is a San Francisco-based global leader in life sciences with activities in Private Equity, Venture Capital, Merchant Banking and Media. The Burrill family of venture capital funds has over $950 million under management and its merchant banking business is one of the industry leaders in life sciences transactions. Burrill publishes a wide range of bio-intelligence reports including its flagship publication, the annual "State of the Industry" report. These publications provide the latest insight, intelligence and information on the life sciences industry.
